Remy Sukhija - Net Worth and Insider Trading

Remy Sukhija Net Worth

The estimated net worth of Remy Sukhija is at least $0 dollars as of 2024-11-13. Remy Sukhija is the Chief Commercial Officer of Madrigal Pharmaceuticals Inc and owns about 0 shares of Madrigal Pharmaceuticals Inc (MDGL) stock worth over $0. Details can be seen in Remy Sukhija's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Remy Sukhija has not made any transactions after 2022-12-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Remy Sukhija

To

Remy Sukhija Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Remy Sukhija owns 1 companies in total, including Madrigal Pharmaceuticals Inc (MDGL) .

Click here to see the complete history of Remy Sukhija’s form 4 insider trades.

Insider Ownership Summary of Remy Sukhija

Ticker Comapny Transaction Date Type of Owner
MDGL Madrigal Pharmaceuticals Inc 2022-12-23 SVP and Chief Comm'l Officer

Remy Sukhija Latest Holdings Summary

Remy Sukhija currently owns a total of 1 stock. Remy Sukhija owns 0 shares of Madrigal Pharmaceuticals Inc (MDGL) as of December 23, 2022, with a value of $0.

Latest Holdings of Remy Sukhija

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MDGL Madrigal Pharmaceuticals Inc 2022-12-23 0 339.25 0

Holding Weightings of Remy Sukhija


Remy Sukhija Form 4 Trading Tracker

According to the SEC Form 4 filings, Remy Sukhija has made a total of 1 transactions in Madrigal Pharmaceuticals Inc (MDGL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Madrigal Pharmaceuticals Inc is the sale of 30,000 shares on December 23, 2022, which brought Remy Sukhija around $8 Million.

Insider Trading History of Remy Sukhija

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Remy Sukhija Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Remy Sukhija Ownership Network

Ownership Network List of Remy Sukhija

No Data

Ownership Network Relation of Remy Sukhija

Insider Network Chart

Remy Sukhija Owned Company Details

What does Madrigal Pharmaceuticals Inc do?

Who are the key executives at Madrigal Pharmaceuticals Inc?

Remy Sukhija is the SVP and Chief Comm'l Officer of Madrigal Pharmaceuticals Inc. Other key executives at Madrigal Pharmaceuticals Inc include director & President and CEO William John Sibold , Senior VP & Chief Pharma Dev. Robert E. Waltermire , and director & 10 percent owner Fred B Craves .

Madrigal Pharmaceuticals Inc (MDGL) Insider Trades Summary

Over the past 18 months, Remy Sukhija made no insider transaction in Madrigal Pharmaceuticals Inc (MDGL). Other recent insider transactions involving Madrigal Pharmaceuticals Inc (MDGL) include a net purchase of 424,685 shares made by Baker Bros. Advisors Lp , a net sale of 12,736 shares made by Robert E. Waltermire , and a net sale of 21,000 shares made by Richard S Levy .

In summary, during the past 3 months, insiders sold 16,363 shares of Madrigal Pharmaceuticals Inc (MDGL) in total and bought 0 shares, with a net sale of 16,363 shares. During the past 18 months, 313,930 shares of Madrigal Pharmaceuticals Inc (MDGL) were sold and 424,685 shares were bought by its insiders, resulting in a net purchase of 110,755 shares.

Madrigal Pharmaceuticals Inc (MDGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Madrigal Pharmaceuticals Inc Insider Transactions

No Available Data

Remy Sukhija Mailing Address

Above is the net worth, insider trading, and ownership report for Remy Sukhija. You might contact Remy Sukhija via mailing address: 48 Pheasant Hill Road, Princeton Nj 08540.